EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Study on the dependence potential of (+)-5-oxo-D-prolinepiperidinamide monohydrate (NS-105) in rhesus monkeys and rats






Oyo Yakuri 55(2-3): 61-69

Study on the dependence potential of (+)-5-oxo-D-prolinepiperidinamide monohydrate (NS-105) in rhesus monkeys and rats

The dependence potential of (+)-5-OXO-D-prolinepiperidinamide monohydrate (NS-105) was assessed by four experiments in rhesus monkeys and rats. In gross behavioral observation for acute CNS effects with intravenous administration of NS-105 up to 128 mg/kg in 3 monkeys per dose, no specific effects were observed. In intravenous self-administration of NS-105 at 1, 4 and 16 mg/kg/infusion in 4 monkeys, no active intake was observed.


Accession: 009481571



Related references

Yanagita, T.; Takada, K., 1998: Study on the dependence potential of -5-oxo-D-prolinepiperidinamide monohydrate in rhesus monkeys and rats. The dependence potential of (+)-5-OXO-D-prolinepiperidinamide monohydrate (NS-105) was assessed by four experiments in rhesus monkeys and rats. In gross behavioral observation for acute CNS effects with intravenous administration of NS-105 up to 1...

Wakasa, Y.; Takada, K.; Mikami, M.; Yanagita, T., 1987: Assessment of dependence potential of kjk 945 in rhesus monkeys and rats. The dependence potential of KJK-945 was assessed by 5 experiments in rhesus monkeys and rats with the following results. In gross behavioral observations performed in normal rats, single oral administration of KJK-945 at 4, 16, and 64 mg/kg produc...

Yanagita T.; Wakasa Y.; Nakanishi H., 1982: Drug dependence potential of dl 832 tested in rhesus monkeys and rats. The drug dependence potential of DL-832 (dl-glaucine.cntdot.1.5 phosphate) was tested in 5 experiments in rhesus monkeys and rats. In gross behavioral observation in normal monkeys, weak CNS depressant effects such as eye-closing and decreased awa...

Ando, K.; Kawaguchi, T.; Kawakami, Y.; Yanagita, T., 1993: Dependence study on LY170053 in rhesus monkeys and rats. The dependence potential of LY170053 was assessed by experiments in rhesus monkeys and rats. Intragastric administration was used in all experiments except in a physical dependence producing experiment in rats where a drug-admixed food method was...

Wakasa, Y.; Kawaguchi, T.; Yanagita, T., 1994: Dependence study on NK433 in rhesus monkeys and rats. The dependence potential of NK433 was assessed in rhesus monkeys and rats with the following results. 1. Grossly observable changes following the intravenous administration of NK433 included such signs as eye-closing, decreased spontaneous motor a...

Ando K.; Kawaguchi T.; Yanagita T., 1991: Dependence study on ly 127809 in rhesus monkeys and rats. The dependence potential of LY127809 was assessed by experiments in rhesus monkeys and rats with the following results. In gross behavioral observation in rhesus monkeys, intragastric administration of LY127809 at 0.06 .apprx. 32 mg/kg was tested...

Takada, K.; Yanagita, T., 1997: Drug dependence study on vigabatrin in rhesus monkeys and rats. The dependence potential of vigabatrin (gamma-vinyl GABA; R(-)/S(+)-4-amino-5-hexenoic acid, CAS 60643-86-9, MDL 71,754) was assessed in rhesus monkeys and rats. In the test of cross physical dependence potential, morphine- and barbital-dependent...

Tsukada, H.; Yamazaki, S.; Noda, A.; Inoue, T.; Matsuoka, N.; Kakiuchi, T.; Nishiyama, S.; Nishimura, S., 1999: FK960 -p-fluorobenzamide monohydrate, a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966 A positron emission tomography study with unanesthetized rhesus monkeys. The interactions of FK960 (N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate), a novel potential antidementia drug, with cholinergic and glutamatergic neuronal systems were evaluated with respect to its effects on the regional cerebral bloo...

Miyasato K.; Yanagita T., 1978: Studies on drug dependence part 30 dependence potential of thebaine in rhesus monkeys. Japanese Journal of Pharmacology 28(SUPPL): 62P

Tsukada, H.; Yamazaki, S.; Noda, A.; Inoue, T.; Matsuoka, N.; Kakiuchi, T.; Nishiyama, S.; Nishimura, S., 1999: FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys. The interactions of FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, with cholinergic and glutamatergic neuronal systems were evaluated with respect to its effects on the regional cerebral bloo...